These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. How does tetanus toxin act? Mellanby J; Green J Neuroscience; 1981; 6(3):281-300. PubMed ID: 6164010 [No Abstract] [Full Text] [Related]
4. Gangliosides are the binding substances in neural cells for tetanus and botulinum toxins in mice. Kitamura M; Takamiya K; Aizawa S; Furukawa K; Furukawa K Biochim Biophys Acta; 1999 Oct; 1441(1):1-3. PubMed ID: 10526222 [TBL] [Abstract][Full Text] [Related]
5. Interaction of solid-phase gangliosides with tetanus toxin and toxoid. Habermann E; Tayot JL Toxicon; 1985; 23(6):913-20. PubMed ID: 4095706 [TBL] [Abstract][Full Text] [Related]
6. The effect of the treatment of crude tetanus toxin with ganglioside cerebroside complex on sphincter paralysis in the rabbit's eye. Mellanby J; Pope D; Ambache N J Gen Microbiol; 1968 Mar; 50(3):479-86. PubMed ID: 5652077 [No Abstract] [Full Text] [Related]
7. Attenuation of inhibitory processes in the central nervous system by tetanus toxin: an in vitro study on rat hippocampal slices. Wieraszko A Life Sci; 1985 Dec; 37(22):2059-65. PubMed ID: 4068894 [TBL] [Abstract][Full Text] [Related]
8. On the similarity of tetanus and cholera toxins. van Heyningen WE Naunyn Schmiedebergs Arch Pharmacol; 1973; 276(3-4):289-95. PubMed ID: 4268160 [No Abstract] [Full Text] [Related]
9. Studies on tetanus toxin and toxoid. IV. Interaction of formaldehyde with tetanus toxin. Dawson DJ; Mauritzen CM Aust J Biol Sci; 1969 Oct; 22(5):1217-27. PubMed ID: 5392877 [No Abstract] [Full Text] [Related]
10. Studies on the immunotherapy of tetanus. I. Purification and characterization of tetanus toxin. Dowdle EB; Koper G; Schaafsma AW S Afr J Med Sci; 1970 Dec; 35(3):75-80. PubMed ID: 4938392 [No Abstract] [Full Text] [Related]
12. The mechanism of action of tetanus toxin: effect on synaptic processes and some particular features of toxin binding by the nervous tissue. Kryzhanovsky GN Naunyn Schmiedebergs Arch Pharmacol; 1973; 276(3-4):247-70. PubMed ID: 4351283 [No Abstract] [Full Text] [Related]
13. Botulinum A neurotoxin unlike tetanus toxin acts via a neuraminidase sensitive structure. Bigalke H; Müller H; Dreyer F Toxicon; 1986; 24(11-12):1065-74. PubMed ID: 3564058 [TBL] [Abstract][Full Text] [Related]
14. Subcellular fixation of tetanus toxin in susceptible and resistant species. Patel AA; Rao SS Br J Pharmacol Chemother; 1966 Mar; 26(3):740-7. PubMed ID: 5959216 [No Abstract] [Full Text] [Related]
15. On the similarity of tetanus and botulinum toxins. Mellanby J; Thompson PA; Hampden N Naunyn Schmiedebergs Arch Pharmacol; 1973; 276(3-4):303-10. PubMed ID: 4268161 [No Abstract] [Full Text] [Related]
16. Effects and mechanisms of polypeptide neurotoxins that act presynaptically. Howard BD; Gundersen CB Annu Rev Pharmacol Toxicol; 1980; 20():307-36. PubMed ID: 6247959 [No Abstract] [Full Text] [Related]
17. Antagonism of synaptic inhibition in the rat substantia nigra by tetanus toxin [proceedings]. Davies J; Tongroach P Br J Pharmacol; 1977 Mar; 59(3):489P. PubMed ID: 843727 [No Abstract] [Full Text] [Related]
18. Different response of the knockout mice lacking b-series gangliosides against botulinum and tetanus toxins. Kitamura M; Igimi S; Furukawa K; Furukawa K Biochim Biophys Acta; 2005 Jun; 1741(1-2):1-3. PubMed ID: 15919183 [TBL] [Abstract][Full Text] [Related]
19. Gangliosides mediate inhibitory effects of tetanus and botulinum A neurotoxins on exocytosis in chromaffin cells. Marxen P; Fuhrmann U; Bigalke H Toxicon; 1989; 27(8):849-59. PubMed ID: 2781584 [TBL] [Abstract][Full Text] [Related]
20. Serological identification and physical-chemical properties of the non-spasmogenic principle (NSP) in tetanus toxin. Tomita JT; Feigen GA Immunochemistry; 1969 May; 6(3):421-35. PubMed ID: 5786935 [No Abstract] [Full Text] [Related] [Next] [New Search]